AUS
NZ
UK
CA
USA
IND
Healthcare
Healthcare Stocks See Renewed Optimism After Market Downturn
March 06, 2025 12:23 PM AEDT| By Team Kalkine MediaHighlights,Integral Diagnostics (IDX),and,Cochlear (,ASX:COH,),receive an improved outlook following recent market declines.,Integral Diagnostics (IDX),expected to,benefit,from regulatory changes and new contracts.,ResMed (,ASX:RMD,),shows strong ear...
Enlitic Partners with GE HealthCare for US Rollout of AI-Driven Genesis Imaging Solutions
March 06, 2025 01:50 AM AEDT| By Team Kalkine MediaHighlights,Enlitic (ENL) collaborates with GE HealthCare to enhance cloud-enabled medical imaging.,The Genesis portfolio introduces AI-powered tools for efficient imaging data management.,Amazon Web Services (AWS) supports the cloud deployment of Gen...
Clarity Pharmaceuticals Expands Cancer Research with New Copper-64 Isotope Supply Agreement
March 06, 2025 01:44 AM AEDT| By Team Kalkine MediaHighlights,Clarity Pharmaceuticals (CU6) secures copper-64 supply for prostate cancer trials,Fast-track designation by the FDA accelerates research progress,Partnership strengthens local research and patient care initiatives,Clarity Pharmaceuticals (...
Recce Pharmaceuticals (ASX:RCE) Faces Continued Market Pressure Amid Revenue Growth
March 06, 2025 12:53 AM AEDT| By Team Kalkine MediaHighlights,Recce Pharmaceuticals (ASX:RCE) sees a 12% decline this week, adding to its three-year loss of 58%.,Despite a 49% annual revenue growth rate, market sentiment remains cautious.,Investors weigh long-term potential against near-term stock pr...
Neuren Pharmaceuticals’ (ASX:NEU) Long-Term Growth Shines Despite Recent Market Pullback
March 05, 2025 11:04 PM AEDT| By Team Kalkine MediaHighlights,Long-term surge: Neuren Pharmaceuticals' (NEU) stock has soared 597% over the past five years.,Recent turbulence: A 15% decline in the past month and a 37% drop over the last year.,Profitability milestone: Transition from losses to profita...
Ramsay Health Care (ASX:RHC): Unpacking the Earnings Dip and What Lies Ahead
March 05, 2025 10:39 PM AEDT| By Team Kalkine MediaHighlights,Unusual items impacted Ramsay Health Care’s (ASX:RHC) recent earnings.,One-time expenses suggest potential for stronger financials moving forward.,Future performance hinges on key factors beyond the latest results.,Ramsay Health Care (ASX:...
Oceania Healthcare (ASX:OCA) Strengthens Financial Position and Optimizes Operations for Growth
March 05, 2025 12:52 PM AEDT| By Team Kalkine MediaHighlights,Successful Debt Refinance:,Strong lender demand led to,optimal,pricing, extended tenor, and unchanged covenants.,Sales Growth and Expansion:,New sales,volumes up 29%, with ongoing developments enhancing occupancy.,Strategic Business,Optimi...
Clarity Pharmaceuticals Rises 7% Amid Promising Trial Results and New Supply Agreement
March 05, 2025 11:06 AM AEDT| By Team Kalkine MediaHighlights,Trial Progression:,Clarity Pharmaceuticals completed the Dose Escalation Phase of its SECuRE trial, with approval to advance to Phase II.,Safety and Efficacy Success:,The Safety Review Committee recommended progressing the trial based on p...
Health Update: Clarity, Telix's Smaller Counterpart, Progresses to Next Stage of Prostate Cancer Treatment Trial
March 05, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Clarity Pharmaceuticals reports progress in prostate cancer therapy with a high response rate.,Race Oncology launches a clinical trial exploring the cardio-protective benefits of bisantrene.,Immuron expands its IBS treatment offerings acro...
Race secures significant contract to progress trial of cardioprotective anticancer therapy
March 05, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Race Oncology collaborates with George Clinical for the clinical development of RC220 bisantrene.,The trial is designed to assess RC220’s safety when combined with doxorubicin in advanced solid tumors.,Work order approval is set at approxi...
Compumedics Receives FDA Approval for Another In-Home Sleep Testing Device
March 05, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Compumedics Limited (ASX:CMP) receives FDA clearance for its Falcon home sleep testing solution.,Falcon enhances Compumedics' Somfit technology, supporting its expansion in the US sleep diagnostics market.,Strong sales momentum in the US a...
Biocurious: Given Recce's proximity, it was the ideal location to initiate a trial related to diabetes.
March 05, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Strategic Expansion:,Recce Pharmaceuticals is advancing its synthetic antibiotic R327 into a phase III trial in Indonesia, addressing the widespread issue of diabetic foot infections while leveraging the country's growing healthcare secto...
LTR Pharma Discovers Accelerated Route to U.S. Erectile Dysfunction Market
March 05, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlight,LTR Pharma introduces Roxus, aiming for early US market entry before FDA approval.,Healthcare stocks see minimal impact from Australia's recent federal budget.,Prescient Therapeutics launches a phase 2a trial for a novel blood cancer treatm...
Dimerix sees slight increase as initial Japanese payment for DMX-200 is received
March 04, 2025 04:33 PM AEDT| By Team Kalkine MediaHighlights,Dimerix Ltd (ASX:DXB) receives initial $3.2 million payment from FUSO Pharmaceutical Industries as part of a strategic partnership in Japan.,The collaboration aims to commercialize DMX-200, a drug targeting Focal Segmental Glomeruloscleros...
Invion secures $2 million through share placement to advance cancer research efforts.
March 04, 2025 04:30 PM AEDT| By Team Kalkine MediaHighlights:,Invion Ltd is advancing its Photosoft technology to develop treatments for various cancer types.,Collaboration with the Peter MacCallum Cancer Centre supports ongoing clinical trial initiatives.,Additional research efforts focus on gliobl...
Firebrick Pharma (ASX:FRE) Gains Strategic $1.1M Investment to Fuel Growth in Asia
March 04, 2025 02:13 PM AEDT| By Team Kalkine MediaHighlights,Firebrick Pharma (FRE) secures a $1.1 million investment from Pharma Nutria N.A., Inc.,The deal includes a 13% premium to the 15-day VWAP and a 12-month escrow period.,Funds to support,Nasodine,® Nasal Spray marketing and product developme...
Healthscope Faces Rental Payment Issues on HMC-Owned Hospitals
March 04, 2025 12:10 PM AEDT| By Team Kalkine MediaHighlights,Healthscope (,ASX:HSO,) has not fully paid its March rent for 11 hospitals owned by,HealthCo,Healthcare & Wellness REIT (,ASX:HCW,).,HealthCo,Healthcare has issued breach notices and received partial payment.,The REIT is considering altern...
Pro Medicus (ASX:PME) Gains Momentum: What’s Driving Investor Interest?
March 04, 2025 12:08 PM AEDT| By Team Kalkine MediaHighlights,Pro Medicus (,ASX:PME,) shares have risen 3.6% since the start of 2025.,The healthcare IT sector is projected to grow at over 15% annually through 2030.,Ethical investing trends could further boost healthcare sector appeal.,Pro Medicus (AS...
Imugene Welcomes Darren Keamy as CFO and Company Secretary
March 04, 2025 12:04 PM AEDT| By Team Kalkine MediaHighlights,Imugene,(,ASX:IMU,) appoints experienced finance leader Darren,Keamy,as CFO and company secretary.,Keamy,brings,nearly two,decades of,expertise,from,Clinuvel,Pharmaceuticals (,ASX:CUV,).,His strategic financial leadership contributed to,Cl...
Imricor Medical Systems Strengthens Market Position with New Funding
March 04, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Imricor Medical Systems secures significant financial backing through a capital raise, reinforcing its commitment to advancing MRI-compatible cardiac ablation technology.,The funding will support ongoing clinical trials, regulatory effort...
Advertise your brand on Kalkine Media